SCHEMBL19126538

SCHEMBL19126538

CC(C)(C)OC(=O)N1CCN(C(=O)Cn2ccc3cc(-n4cc(CC(=O)O)nn4)ccc32)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 4/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LOXL2 Q9Y4K0 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ KDM1A O60341 9/20 0.42
▸ GRM5 P41594 3/20 0.41
▸ GRM1 Q13255 3/20 0.41
▸ TUBB4A P04350 1/20 0.39
▸ TUBB P07437 1/20 0.39
▸ TUBA3C P0DPH7 1/20 0.39
▸ TUBA1B P68363 1/20 0.39
▸ TUBA4A P68366 1/20 0.39
▸ TUBB4B P68371 1/20 0.39
▸ TUBB3 Q13509 1/20 0.39
▸ TUBB2A Q13885 1/20 0.39
▸ TUBB8 Q3ZCM7 1/20 0.39
▸ TUBA3E Q6PEY2 1/20 0.39
▸ TUBA1A Q71U36 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127488 0.86 POLB (0.45) GPR119ALDH1A1MEN1GLAKMT2A
SCHEMBL20676213 0.83 POLB (0.45) GPR119ALDH1A1MEN1GLAKMT2A
SCHEMBL19126753 0.80 GPR119 (0.52) GPR119ALDH1A1MEN1KMT2AKDM1A
SCHEMBL19144674 0.79 ATM (0.47) ALDH1A1GLAATM
SCHEMBL19127388 0.79 GPR119 (0.54) GPR119ALDH1A1MEN1KMT2AGRM5
SCHEMBL19126500 0.78 GPR119 (0.49) GPR119ALDH1A1MEN1GLAKMT2A
SCHEMBL19126721 0.77 GPR119 (0.58) GPR119MEN1KMT2AGRM5GRM1
SCHEMBL19145537 0.77 LOXL2 (0.47) ALDH1A1LOXL2MEN1KMT2A
SCHEMBL20676201 0.77 KRAS (0.47) LOXL2
SCHEMBL19146128 0.76 GPR119 (0.50) GPR119MEN1KMT2AGRM5GRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939314-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2024-03-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
EP-3402792-A1 QUINOLIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-11-21 — — EP disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174241-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-11939314-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-10669251-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885
US-11186562-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885ALDH1A1 2614/4885LOXL2 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback